Castle Creek licenses US rights to Fibrocell's FCX007 RDEB gene therapy candidate for up to $135mm
- Gene Therapy, Cell Therapy
- Large Molecule
- Specialty Pharmaceuticals
- Includes Royalty or Profit Split Information
- R+D and Marketing-Licensing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.